30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Implanet Receives FDA Clearance and CE Mark for Jazz Claw Implant -

Implanet received FDA 510(k) clearance and CE Mark approval for the Jazz Claw®, a hybrid-implant designed to treat degenerative spinal pathologies in adults, including kyphosis.

The Jazz Claw seeks to provide autostable posterior fixation by replacing traditional hook-and-screw fixation systems.

Source: Implanet

The addition of Jazz Claw contributes to Implanet’s product portfolio for the treatment of degenerative spinal pathologies. Earlier this quarter, the company received regulatory approval for the Jazz Lock Implant.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.